Leonid Zeitlin

1.7k total citations
32 papers, 1.1k citations indexed

About

Leonid Zeitlin is a scholar working on Genetics, Rheumatology and Nutrition and Dietetics. According to data from OpenAlex, Leonid Zeitlin has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 11 papers in Rheumatology and 9 papers in Nutrition and Dietetics. Recurrent topics in Leonid Zeitlin's work include Connective tissue disorders research (14 papers), Parathyroid Disorders and Treatments (8 papers) and Bone and Dental Protein Studies (6 papers). Leonid Zeitlin is often cited by papers focused on Connective tissue disorders research (14 papers), Parathyroid Disorders and Treatments (8 papers) and Bone and Dental Protein Studies (6 papers). Leonid Zeitlin collaborates with scholars based in Israel, Canada and United States. Leonid Zeitlin's co-authors include Francis H. Glorieux, Frank Rauch, Horacio Plotkin, François Fassier, Craig F. Munns, Rose Travers, Yael Lebenthal, Avivit Brener, Mona Al Mukaddam and Stephen P. Dunn and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, PEDIATRICS and Journal of Bone and Mineral Research.

In The Last Decade

Leonid Zeitlin

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leonid Zeitlin Israel	14	686	439	348	342	263	32	1.1k
Moira Cheung United Kingdom	22	752 1.1×	294 0.7×	287 0.8×	264 0.8×	245 0.9×	60	1.2k
Fleur S. van Dijk Netherlands	10	846 1.2×	166 0.4×	370 1.1×	225 0.7×	80 0.3×	11	999
Telma Palomo Canada	14	510 0.7×	149 0.3×	222 0.6×	194 0.6×	133 0.5×	24	716
Heike Hoyer‐Kuhn Germany	17	378 0.6×	187 0.4×	231 0.7×	164 0.5×	139 0.5×	43	773
Friederike Koerber Germany	15	677 1.0×	140 0.3×	309 0.9×	159 0.5×	72 0.3×	31	1.1k
Marilyn H Kelly United States	20	216 0.3×	705 1.6×	856 2.5×	59 0.2×	89 0.3×	22	1.5k
Yasuhisa Ohata Japan	17	345 0.5×	141 0.3×	154 0.4×	47 0.1×	68 0.3×	54	851
Robert D. Tiegs United States	18	139 0.2×	635 1.4×	210 0.6×	138 0.4×	397 1.5×	27	1.2k
Beth A Brillante United States	20	132 0.2×	510 1.2×	726 2.1×	65 0.2×	58 0.2×	27	1.2k
Rivka Dresner Pollak Israel	13	173 0.3×	89 0.2×	85 0.2×	154 0.5×	151 0.6×	15	685

Countries citing papers authored by Leonid Zeitlin

Since Specialization

Citations

This map shows the geographic impact of Leonid Zeitlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonid Zeitlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonid Zeitlin more than expected).

Fields of papers citing papers by Leonid Zeitlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonid Zeitlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonid Zeitlin. The network helps show where Leonid Zeitlin may publish in the future.

Co-authorship network of co-authors of Leonid Zeitlin

This figure shows the co-authorship network connecting the top 25 collaborators of Leonid Zeitlin. A scholar is included among the top collaborators of Leonid Zeitlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonid Zeitlin. Leonid Zeitlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Landau, Daniel, Miriam Davidovits, Avivit Brener, et al.. (2024). Nephrocalcinosis tendency does not worsen under burosumab treatment for X-linked hypophosphatemic rickets: a multicenter pediatric study. Frontiers in Pediatrics. 12. 1487890–1487890. 2 indexed citations

2.

Brener, Avivit, Roxana Cleper, Guy Baruch, et al.. (2024). Cardiovascular health in pediatric patients with X-linked hypophosphatemia under two years of burosumab therapy. Frontiers in Endocrinology. 15. 1400273–1400273. 1 indexed citations

3.

Seefried, Lothar, Ali S. Alzahrani, Justine Bacchetta, et al.. (2023). XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH). Orphanet Journal of Rare Diseases. 18(S2). 333–333. 4 indexed citations

4.

Hauser, Robert A., Alberto J. Espay, Aaron Ellenbogen, et al.. (2023). IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease. JAMA Neurology. 80(10). 1062–1062. 20 indexed citations

5.

Espay, Alberto J., Robert A. Hauser, Rohit Dhall, et al.. (2023). Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE‐PD Open‐Label Extension Study. Movement Disorders. 39(2). 428–432. 4 indexed citations

6.

Levy‐Shraga, Yael, Avivit Brener, Yael Lebenthal, et al.. (2023). Linear growth of children with X-linked hypophosphatemia treated with burosumab: a real-life observational study. European Journal of Pediatrics. 182(11). 5191–5202. 6 indexed citations

7.

Zeitlin, Leonid, et al.. (2022). Dental health of pediatric patients with X-linked hypophosphatemia (XLH) after three years of burosumab therapy. Frontiers in Endocrinology. 13. 947814–947814. 15 indexed citations

8.

Ovadia, Dror, et al.. (2022). Cementless posterior spinal fusion for the treatment of OI patients with severe spine deformity—a case series. European Spine Journal. 31(6). 1566–1572. 1 indexed citations

9.

Zeitlin, Leonid, et al.. (2022). Massive Cervical Heterotopic Ossification and Extra-Articular Temporomandibular Joint Ankylosis. The Journal of Pediatrics. 248. 127–128. 1 indexed citations

10.

Hauser, Robert A., Leonid Zeitlin, Stanley E. Fisher, & Richard D’Souza. (2020). Carbidopa and Levodopa Extended Release Capsules in Patients with and without Troublesome and Non-Troublesome Dyskinesia. Journal of Parkinson s Disease. 10(3). 915–925. 3 indexed citations

11.

Hauser, Robert A., Leonid Zeitlin, Stanley E. Fisher, & Richard D’Souza. (2020). Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®). Parkinsonism & Related Disorders. 82. 133–137. 3 indexed citations

12.

Levy‐Shraga, Yael, Dalit Modan‐Moses, Shlomo Wientroub, Dror Ovadia, & Leonid Zeitlin. (2019). The effect of growth hormone treatment in a child with tricho-rhino-phalangeal syndrome: A case report and review of the literature. European Journal of Medical Genetics. 63(4). 103830–103830. 7 indexed citations

13.

Kämpe, Anders, Alice Costantini, Yael Levy‐Shraga, et al.. (2017). PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization. Journal of Bone and Mineral Research. 32(12). 2394–2404. 36 indexed citations

14.

Kaplan, Frederick S., Leonid Zeitlin, Stephen P. Dunn, et al.. (2017). Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases. Bone. 109. 281–284. 26 indexed citations

15.

Zeitlin, Leonid, Frank Rauch, Rose Travers, Craig F. Munns, & Francis H. Glorieux. (2005). The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta Type V. Bone. 38(1). 13–20. 43 indexed citations

16.

Zeitlin, Leonid, Elad Segev, A. Fried, & S. Wientroub. (2003). Effects of long‐term administration of N‐3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice. Journal of Cellular Biochemistry. 90(2). 347–360. 13 indexed citations

17.

Zeitlin, Leonid, Frank Rauch, Horacio Plotkin, & Francis H. Glorieux. (2003). Height and Weight Development During Four Years of Therapy With Cyclical Intravenous Pamidronate in Children and Adolescents With Osteogenesis Imperfecta Types I, III, and IV. PEDIATRICS. 111(5). 1030–1036. 143 indexed citations

18.

Zeitlin, Leonid, Murray B. Resnick, Fred M. Konikoff, et al.. (2003). DIVERGENT PATTERNS OF EXTRACELLULAR MATRIX PROTEIN EXPRESSION IN NEONATAL VERSUS ADULT LIVER FIBROSIS. Pediatric Pathology & Molecular Medicine. 22(4). 349–362. 7 indexed citations

19.

Rauch, Frank, Horacio Plotkin, Rose Travers, Leonid Zeitlin, & Francis H. Glorieux. (2003). Osteogenesis Imperfecta Types I, III, and IV: Effect of Pamidronate Therapy on Bone and Mineral Metabolism. The Journal of Clinical Endocrinology & Metabolism. 88(3). 986–992. 114 indexed citations

20.

Zeitlin, Leonid, Murray B. Resnick, Fred M. Konikoff, et al.. (2003). DIVERGENT PATTERNS OF EXTRACELLULAR MATRIX PROTEIN EXPRESSION IN NEONATAL VERSUS ADULT LIVER FIBROSIS. Pediatric Pathology & Molecular Medicine. 22(4). 349–362. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact